The UK Health Security Agency has confirmed five new cases of meningitis in Kent, bringing the total number of investigated cases in the regional cluster to 20. The outbreak, which has resulted in the deaths of a University of Kent student and a Year 13 pupil from Faversham, is primarily affecting young adults.
Getty Images
Health Secretary Wes Streeting addressed the House of Commons, describing the situation as an “unprecedented” and “explosive” outbreak. Despite the rapid local transmission, health officials maintain that the risk of the disease spreading widely beyond Kent remains low.
Emergency Public Health Response
Of the 20 total cases, nine are laboratory-confirmed and 11 remain under investigation. Officials verified that six of the confirmed cases are the meningitis B (MenB) strain. The most recent numerical data was logged by the UKHSA at 5:00 PM local time on Tuesday, March 17, 2026.
In response to the cluster, a targeted MenB vaccination program is launching for approximately 5,000 students living in University of Kent halls of residence in Canterbury. Additionally, around 2,500 doses of prophylactic antibiotics have been administered to contacts. This includes individuals who visited Club Chemistry, a local nightclub, in early March.
Vaccine Shortages and Policy Scrutiny
The rapid emergence of cases has triggered a rush on private MenB vaccines, leading to supply shortages at regional pharmacies. Some providers are quoting prices up to £220 for a two-jab course as parental demand surges.
The outbreak has renewed scrutiny on national immunization policies. The MenB vaccine was introduced to the NHS routine childhood immunization program in 2015, but eligibility was restricted to infants. This limitation has left current teenagers and young adults over the age of 10 largely unvaccinated against the strain. The UK Joint Committee on Vaccination and Immunisation is currently facing pressure to re-evaluate these eligibility rules.
Historical Context of Meningococcal Disease
While a cluster of 20 cases in a concentrated timeframe is highly unusual, national statistics indicate that invasive meningococcal disease has decreased significantly over recent decades due to successful immunization programs for other strains. In the 2024-25 period, England recorded 378 total cases of invasive meningococcal disease, with over 80 percent identified as MenB. This represents a massive reduction compared to the peak of 2,600 deaths recorded during the 1999/2000 period.